Role of Preoperative Biliary Stenting and Preoperative Preparation Before Pancreaticoduodenectomy

  • Rishi Batra
  • Chandrakanth AreEmail author


Surgical resection remains the only potentially curative treatment option for patients diagnosed with pancreatic cancer. Pancreaticoduodenectomy is a morbid procedure that is fraught with an acceptable mortality rate, but a high morbidity rate. Preoperative biliary stenting can be used as a bridge to surgery for pancreatic cancer, to minimize the risk of developing cholangitis and to facilitate the administration of neoadjuvant therapy in patients with locally advanced pancreatic cancer. It can also be used for palliation in patients with unresectable disease. However, biliary stenting is not recommended for routine use preoperatively and must be individualized to the patient. Prior to pancreaticoduodenectomy, a thorough, systematic, and methodical approach to risk stratification and preoperative planning is mandatory to improve patient selection and optimize outcomes. A multidisciplinary team approach consisting of surgeons, gastroenterologists, medical oncologists, radiation oncologists, and pain specialists helps to deliver comprehensive care to patients in preparation for the operation.


  1. 1.
    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.CrossRefGoogle Scholar
  2. 2.
    Gong Z, Holly EA, Bracci PM. Survival in population-based pancreatic cancer patients: San Francisco Bay Area, 1995-1999. Am J Epidemiol. 2011;174:1373–81.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Grover S, Syngal S. Hereditary pancreatic cancer. Gastroenterology. 2010;139(4):1076–80, 1080.e1-2.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Cameron JL, He J. Two thousand consecutive pancreaticoduodenectomies. J Am Coll Surg. 2015;220:530–6.CrossRefPubMedGoogle Scholar
  5. 5.
    Whipple AO, Parsons WB, Mullins CR. Treatment of carcinoma of the ampulla of Vater. Ann Surg. 1935;102(4):763–79.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Denning DA, Ellison EC, Carey LC. Preoperative percutaneous transhepatic biliary decompression lowers operative morbidity in patients with obstructive jaundice. Am J Surg. 1981;141:61–5.CrossRefPubMedGoogle Scholar
  7. 7.
    Soehendra N, Reynders-Frederix V. Palliative bile duct drainage—a new endoscopic method of introducing a transpapillary drain. Endoscopy. 1980;12:8–11.CrossRefPubMedGoogle Scholar
  8. 8.
    Green J, Beyar R, Bomzon L, Finberg JP, Better OS. Jaundice, the circulation and the kidney. Nephron. 1984;37:145–52.CrossRefPubMedGoogle Scholar
  9. 9.
    Parks RW, Halliday MI, McCrory DC, Erwin P, Smye M, Diamond T, Rowlands BJ. Host immune responses and intestinal permeability in patients with jaundice. Br J Surg. 2003;90:239–45.CrossRefPubMedGoogle Scholar
  10. 10.
    Rodarte-Shade M, Kahaleh M. Stent placement as a bridge to surgery in malignant biliary obstruction (pancreatic cancer, distal bile duct cancer, and hilar tumors). Gastrointest Interv. 2015;4:21–6.CrossRefGoogle Scholar
  11. 11.
    Nakayama T, Ikeda A, Okuda K. Percutaneous transhepatic drainage of the biliary tract. Technique and results in 104 cases. Gastroenterology. 1978;74:554–9.PubMedGoogle Scholar
  12. 12.
    Gundry SR, Strodel WE, Knol JA, Eckhauser FE, Thompson NW. Efficacy of preoperative biliary tract decompression in patients with obstructive jaundice. Arch Surg. 1984;119:703–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Smith RC, Pooley M, George CRP, Faithful GR. Preoperative percutaneous transhepatic internal drainage in obstructive jaundice: a randomized, controlled trial examining renal function. Surgery. 1985;97:641–8.PubMedGoogle Scholar
  14. 14.
    Robison R, Madura J, Scholten D, Lempke R, Rabe F, Glover J, Becker G, Cockerill E, Broadie T. Percutaneous transhepatic drainage for malignant biliary obstruction. Am Surg. 1984;50:329–33.PubMedGoogle Scholar
  15. 15.
    Martignoni ME, Wagner M, Krähenbühl L, Redaelli CA, Friess H, Büchler MW. Effect of preoperative biliary drainage on surgical outcome after pancreatoduodenectomy. Am J Surg. 2001;181:52–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Sewnath ME, Birjmohun RS, Rauws EAJ, Huibregtse K, Obertop H, Gouma DJ. The effect of preoperative biliary drainage on postoperative complications after pancreaticoduodenectomy. J Am Coll Surg. 2001;192:726–34.CrossRefPubMedGoogle Scholar
  17. 17.
    Van Der Gaag NA, De Castro SMM, Rauws EAJ, Bruno MJ, Van Eijck CHJ, Kuipers EJ, Gerritsen JJGM, Rutten J, Greve JW, Hesselink EJ, Klinkenbijl JHG, Rinkes IHMB, Boerma D, Bonsing BA, Van Laarhoven CJ, Kubben FJGM, Van Der Harst E, Sosef MN, Bosscha K, De Hingh IHJT, Th De Wit L, Van Delden OM, Busch ORC, Van Gulik TM, Bossuyt PMM, Gouma DJ. Preoperative biliary drainage for periampullary tumors causing obstructive jaundice; DRainage vs. (direct) OPeration (DROP-trial). BMC Surg. 2007;7:3.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    van dG, Rauws EAJ, van Eijck CHJ, Bruno MJ, van dH, Kubben FJGM, Gerritsen JJGM, Greve JW, Gerhards MF, de Hingh IHJT, Klinkenbijl JH, Nio CY, de Castro SMM, Busch ORC, van Gulik TM, Bossuyt PMM, Gouma DJ. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med. 2010;362:129–37.CrossRefGoogle Scholar
  19. 19.
    Baron TH, Kozarek RA. Preoperative biliary stents in pancreatic cancer—proceed with caution. N Engl J Med. 2010;362:170–2.CrossRefPubMedGoogle Scholar
  20. 20.
    Moss AC, Morris E, Mac Mathuna P. Palliative biliary stents for obstructing pancreatic carcinoma. Cochrane Database Syst Rev. 25;(1):CD004200.Google Scholar
  21. 21.
    Tol JAMG, Van Hooft JE, Timmer R, Kubben FJGM, Van Der Harst E, De Hingh IHJT, Vleggaar FP, Molenaar IQ, Keulemans YCA, Boerma D, Bruno MJ, Schoon EJ, Van Der Gaag NA, Besselink MGH, Fockens P, Van Gulik TM, Rauws EAJ, Busch ORC, Gouma DJ. Metal or plastic stents for preoperative biliary drainage in resectable pancreatic cancer. Gut. 2016;65:1981–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Fang Y, Gurusamy KS, Wang Q, Davidson BR, Lin H, Xie X, Wang C. Pre-operative biliary drainage for obstructive jaundice. Cochrane Database Syst Rev. 2012;9.Google Scholar
  23. 23.
    Baron TH, Petersen BT, Mergener K, Chak A, Cohen J, Deal SE, Hoffinan B, Jacobson BC, Petrini JL, Safdi MA, Faigel DO, Pike IM. Quality indicators for endoscopic retrograde cholangiopancreatography. Am J Gastroenterol. 2006;101:892–7.CrossRefPubMedGoogle Scholar
  24. 24.
    Cotton PB. Income and outcome metrics for the objective evaluation of ERCP and alternative methods. Gastrointest Endosc. 2002;56:S283–90.CrossRefPubMedGoogle Scholar
  25. 25.
    Moss AC, Morris E, Leyden J, MacMathuna P. Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results. Cancer Treat Rev. 2007;33:213–21.CrossRefPubMedGoogle Scholar
  26. 26.
    Sawas T, Al Halabi S, Parsi MA, Vargo JJ. Self-expandable metal stents versus plastic stents for malignant biliary obstruction: a meta-analysis. Gastrointest Endosc. 2015;82:256–267.e7.CrossRefPubMedGoogle Scholar
  27. 27.
    Lawrence C, Howell DA, Conklin DE, Stefan AM, Martin RF. Delayed pancreaticoduodenectomy for cancer patients with prior ERCP-placed, nonforeshortening, self-expanding metal stents: a positive outcome. Gastrointest Endosc. 2006;63:804–7.CrossRefPubMedGoogle Scholar
  28. 28.
    Sun C, Yan G, Li Z, Tzeng C. A meta-analysis of the effect of preoperative biliary stenting on patients with obstructive jaundice. Medicine (Baltimore). 2014;93(26):e189.CrossRefGoogle Scholar
  29. 29.
    Loew BJ, Howell DA, Sanders MK, Desilets DJ, Kortan PP, May GR, Shah RJ, Chen YK, Parsons WG, Hawes RH, Cotton PB, Slivka AA, Ahmad J, Lehman GA, Sherman S, Neuhaus H, Schumacher BM. Comparative performance of uncoated, self-expanding metal biliary stents of different designs in 2 diameters: final results of an international multicenter, randomized, controlled trial. Gastrointest Endosc. 2009;70:445–53.CrossRefPubMedGoogle Scholar
  30. 30.
    Yang KY, Ryu JK, Seo JK, Woo SM, Park JK, Kim Y, Yoon YB. A comparison of the Niti-D biliary uncovered stent and the uncovered Wallstent in malignant biliary obstruction. Gastrointest Endosc. 2009;70:45–51.CrossRefPubMedGoogle Scholar
  31. 31.
    Yoon WJ, Ryu JK, Yang KY, Paik WH, Lee JK, Woo SM, Park JK, Kim Y, Yoon YB. A comparison of metal and plastic stents for the relief of jaundice in unresectable malignant biliary obstruction in Korea: an emphasis on cost-effectiveness in a country with a low ERCP cost. Gastrointest Endosc. 2009;70:284–9.CrossRefPubMedGoogle Scholar
  32. 32.
    Dumonceau J, Tringali A, Blero D, Devière J, Laugiers R, Heresbach D, Costamagna G. Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. 2012;44(03):277–98.Google Scholar
  33. 33.
    Inamdar S, Slattery E, Bhalla R, Sejpal DV, Trindade AJ. Comparison of adverse events for endoscopic vs percutaneous biliary drainage in the treatment of malignant biliary tract obstruction in an Inpatient National Cohort. JAMA Oncol. 2016;2:112–7.CrossRefPubMedGoogle Scholar
  34. 34.
    Allen VB, Gurusamy KS, Takwoingi Y, Kalia A, Davidson BR. Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. Cochrane Database Syst Rev. 2016;6;7:CD009323doi:
  35. 35.
    Liu RC, Traverso LW. Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by computed tomography. Surg Endosc. 2005;19:638–42.CrossRefPubMedGoogle Scholar
  36. 36.
    Thomson BNJ, Parks RW, Redhead DN, Welsh FKS, Madhavan KK, Wigmore SJ, Garden OJ. Refining the role of laparoscopy and laparoscopic ultrasound in the staging of presumed pancreatic head and ampullary tumours. Br J Cancer. 2006;94:213–7.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, Fleisher LA, Froehlich JB, Gusberg RJ, Leppo JA, Ryan T, Schlant RC, Winters WL Jr, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SC Jr. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) 123. J Am Coll Cardiol. 2002;39:542–53.CrossRefPubMedGoogle Scholar
  38. 38.
    Eagle KA, Brundage BH, Chaitman BR, Ewy GA, Fleisher LA, Hertzer NR, Leppo JA, Ryan T, Schlant RC, Spencer WH III, Spittell JA Jr, Twiss RD, Ritchie JL, Cheitlin MD, Gardner TJ, Garson A Jr, Lewis RP, Gibbons RJ, O'Rourke RA, Ryan TJ. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery: Report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation. 1996;93:1278–317.PubMedGoogle Scholar
  39. 39.
    Grønkjær M, Eliasen M, Skov-Ettrup LS, Tolstrup JS, Christiansen AH, Mikkelsen SS, Becker U, Flensborg-Madsen T. Preoperative smoking status and postoperative complications: a systematic review and meta-analysis. Ann Surg. 2014;259:52–71.CrossRefPubMedGoogle Scholar
  40. 40.
    Warner MA, Divertie MB, Tinker JH. Preoperative cessation of smoking and pulmonary complications in coronary artery bypass patients. Anesthesiology. 1984;60:380–3.CrossRefPubMedGoogle Scholar
  41. 41.
    Sorensen LT, Karlsmark T, Gottrup F. Abstinence from smoking reduces incisional wound infection: a randomized controlled trial. Ann Surg. 2003;238:1–5.PubMedPubMedCentralGoogle Scholar
  42. 42.
    Brooks-Brunn JA. Predictors of postoperative pulmonary complications following abdominal surgery. Chest. 1997;111:564–71.CrossRefPubMedGoogle Scholar
  43. 43.
    McAlister FA, Khan NA, Straus SE, Papaioakim M, Fisher BW, Majumdar SR, Gajic O, Daniel M, Tomlinson G. Accuracy of the preoperative assessment in predicting pulmonary risk after nonthoracic surgery. Am J Respir Crit Care Med. 2003;167:741–4.CrossRefPubMedGoogle Scholar
  44. 44.
    Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, Sugarbaker DJ, Donaldson MC, Poss R, Ho KKL, Ludwig LE, Pedan A, Goldman L. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043–9.CrossRefGoogle Scholar
  45. 45.
    Devereaux PJ, Goldman L, Cook DJ, Gilbert K, Leslie K, Guyatt GH. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ. 2005;173:627–34.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Bilimoria KY, Liu Y, Paruch JL, Zhou L, Kmiecik TE, Ko CY, Cohen ME. Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg. 2013;217(5):833–42.e1-3.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Are C, Afuh C, Ravipati L, Sasson A, Ullrich F, Smith L. Preoperative nomogram to predict risk of perioperative mortality following pancreatic resections for malignancy. J Gastrointest Surg. 2009;13:2152–62.CrossRefPubMedGoogle Scholar
  48. 48.
    Berg J, Appelbaum P, Lidz C. Informed consent: legal theory and clinical practice. New York: Oxford University Press; 2001.Google Scholar
  49. 49.
    Perrenoud B, Velonaki V, Bodenmann P, Ramelet A. The effectiveness of health literacy interventions on the informed consent process of health care users: a systematic review protocol. JBI Database System Rev Implement Rep. 2015;13:82–94.CrossRefPubMedGoogle Scholar
  50. 50.
    Lassen K, Coolsen MME, Slim K, Carli F, De Aguilar-Nascimento JE, Schäfer M, Parks RW, Fearon KCH, Lobo DN, Demartines N, Braga M, Ljungqvist O, Dejong CHC. Guidelines for perioperative care for pancreaticoduodenectomy: enhanced recovery after surgery (ERAS®) society recommendations. World J Surg. 2013;37:240–58.CrossRefPubMedGoogle Scholar
  51. 51.
    Gärtner S, Krüger J, Aghdassi A. Nutrition in pancreatic cancer: a review. Gastrointest Tumors. 2016;2(4):195–202. Epub 2016 Jan 8.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Davidson W, Ash S, Capra S, Bauer J, Fearon KCH, von Meyenfeldt MF, Roy A, Gouma DJ, Giacosa A, Van Gossum A, Ash S. Weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancer. Clin Nutr. 2004;23:239–47.CrossRefPubMedGoogle Scholar
  53. 53.
    Ferrucci LM, Bell D, Thornton J, Black G, McCorkle R, Heimburger DC, Saif MW. Nutritional status of patients with locally advanced pancreatic cancer: a pilot study. Support Care Cancer. 2011;19:1729–34.CrossRefPubMedGoogle Scholar
  54. 54.
    Andersson R, Dervenis C, Haraldsen P, Leveau P. Nutritional aspects in the management of pancreatic cancer. Ann Gastroenterol. 2000;13:221–4.Google Scholar
  55. 55.
    Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, Samama CM. Prevention of VTE in nonorthopedic surgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e227S–77S.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Chew HK, Wun T, Harvey D, Zhou H, White RH. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med. 2006;166:458–64.CrossRefPubMedGoogle Scholar
  57. 57.
    Reinke CE, Drebin JA, Kreider S, Kean C, Resnick A, Raper S, Kelz RR. Timing of preoperative pharmacoprophylaxis for pancreatic surgery patients: a venous thromboembolism reduction initiative. Ann Surg Oncol. 2012;19:19–25.CrossRefPubMedGoogle Scholar
  58. 58.
    Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J, Hodgin MB, Sauter PK, Hruban RH, Riall TS, Schulick RD, Choti MA, Lillemoe KD, Yeo CJ. 1423 Pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg. 2006;10:1199–211.CrossRefPubMedGoogle Scholar
  59. 59.
    Shah BC, Smith LM, Ullrich F, Are C. Discharge disposition after pancreatic resection for malignancy: analysis of national trends. HPB (Oxford). 2012;14:201–8.CrossRefGoogle Scholar
  60. 60.
    Shah BC, Ullrich F, Smith L, Leiphrakpam P, Ly Q, Sasson A, Are C. National trends in discharge disposition after hepatic resection for malignancy. HPB (Oxford). 2011;13:96–102.CrossRefGoogle Scholar
  61. 61.
    Balcom JH IV, Rattner DW, Warshaw AL, Chang Y, Fernandez-Del Castillo C. Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg. 2001;136:391–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  1. 1.Department of SurgeryUniversity of Nebraska Medical CenterOmahaUSA

Personalised recommendations